Skip to main content
Year archive

Alteogen Inc. — 2020 filings

All 63 regulatory filings released by Alteogen Inc. (196170) in 2020, sourced directly from the official regulator.

63 Filings
2020 Period
2020 filings (63)
Filing Released Lang
주요사항보고서(유상증자결정)
Capital/Financing Update
2020-12-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-10 Korean
유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2020-12-10 Korean
기타경영사항(자율공시)(바이오의약품 후보물질인 ALT-L9의 임상과 판매에 대한 라이선스계약 체결)
Regulatory Filings
2020-12-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-12-03 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-11-19 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-11-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-11-17 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-11-12 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-11-04 Korean
기타경영사항(특허권취득)(자율공시)(IgG Fc 도메인을 가지는 융합 단백질의 생산방법)
Regulatory Filings
2020-10-21 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-10-14 Korean
[기재정정]기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-10-14 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-10-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-10-05 Korean
풍문또는보도에대한해명(미확정)
Capital/Financing Update
2020-10-05 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-03 Korean
풍문또는보도에대한해명(미확정)
Capital/Financing Update
2020-09-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-09-02 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-08-28 Korean
[기재정정]반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-27 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
풍문또는보도에대한해명(미확정)
Regulatory Filings
2020-08-04 Korean
금전대여결정(자율공시)
Regulatory Filings
2020-07-30 Korean
권리락(무상증자)
Share Issue/Capital Change
2020-07-22 Korean
기타경영사항(특허권취득)(자율공시)(혈액응고 인자 VII/VIIa 융합단백질의 제조방법)
Regulatory Filings
2020-07-10 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2020-07-07 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2020-07-07 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2020-07-07 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-06-30 Korean
투자판단관련주요경영사항(인간 히알루로니다제 원천 기술(ALT-B4) 비독점적 라이센스 계약 체결)
Capital/Financing Update
2020-06-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-06-11 Korean
풍문또는보도에대한해명
Legal Proceedings Report
2020-06-03 Korean
투자판단관련주요경영사항(ADC 유방암 치료제(ALT-P7) 임상 1상 시험 결과 미 임상종양학회(ASCO)에서 발표)
Regulatory Filings
2020-06-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-05-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-05-25 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-17 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-17 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-04-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-09 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2020-04-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-04-01 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-26 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-18 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-06 Korean
주주총회소집공고
AGM Information
2020-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-04 Korean
주주총회집중일개최사유신고
Regulatory Filings
2020-03-04 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-02 Korean
유상증자결정(종속회사의주요경영사항)(제3자배정)
Share Issue/Capital Change
2020-02-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-02-11 Korean